Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA.
Harbin Medical University, Harbin, Heilongjiang Province, China.
J Dig Dis. 2023 May;24(5):321-331. doi: 10.1111/1751-2980.13201. Epub 2023 Aug 7.
Postponed open necrosectomy or minimally invasive intervention has become the treatment option for necrotizing pancreatitis. Nevertheless, several studies point to the safety and efficacy of early intervention for necrotizing pancreatitis. Therefore, we conducted a systematic review and meta-analysis to compare clinical outcomes of acute necrotizing pancreatitis between early and late intervention.
Literature search was performed in multiple databases for articles that compared the safety and clinical outcomes of early (<4 weeks from the onset of pancreatitis) versus late intervention (≥4 weeks from the onset of pancreatitis) for necrotizing pancreatitis published up to August 31, 2022. The meta-analysis was performed to determine pooled odds ratio (OR) of mortality rate and procedure-related complications.
Fourteen studies were included in the final analysis. For open necrosectomy intervention, the overall pooled OR of mortality rate with the late intervention compared with early intervention was 7.09 (95% confidence interval [CI] 2.33-21.60; I = 54%; P = 0.0006). For minimally invasive intervention, the overall pooled OR of mortality rate with the late intervention compared with early intervention was 1.56 (95% CI 1.11-2.20; I = 0%; P = 0.01). The overall pooled OR of pancreatic fistula with the late minimally invasive intervention compared with early intervention was 2.49 (95% CI 1.75-3.52; I = 0%; P < 0.00001).
These results showed the benefit of late interventions in patients with necrotizing pancreatitis in both minimally invasive procedures and open necrosectomy. Late intervention is preferred in the management of necrotizing pancreatitis.
延期开放坏死组织清除术或微创介入已成为治疗坏死性胰腺炎的选择。然而,有几项研究指出早期干预坏死性胰腺炎的安全性和有效性。因此,我们进行了一项系统评价和荟萃分析,以比较早期(胰腺炎发病后<4 周)与晚期(胰腺炎发病后≥4 周)干预对急性坏死性胰腺炎的临床结局。
在多个数据库中检索比较坏死性胰腺炎早期(胰腺炎发病后<4 周)与晚期(胰腺炎发病后≥4 周)干预的安全性和临床结局的文章,检索时间截至 2022 年 8 月 31 日。进行荟萃分析以确定死亡率和与操作相关的并发症的汇总优势比(OR)。
最终分析纳入了 14 项研究。对于开放坏死组织清除术干预,与早期干预相比,晚期干预的总体死亡率汇总 OR 为 7.09(95%置信区间 [CI] 2.33-21.60;I²=54%;P=0.0006)。对于微创介入,与早期干预相比,晚期干预的死亡率汇总 OR 为 1.56(95% CI 1.11-2.20;I²=0%;P=0.01)。与早期微创干预相比,晚期微创干预的胰瘘总体汇总 OR 为 2.49(95% CI 1.75-3.52;I²=0%;P<0.00001)。
这些结果表明,在微创程序和开放坏死组织清除术中,晚期干预对坏死性胰腺炎患者有益。在坏死性胰腺炎的管理中,晚期干预是首选。